chronic kidney disease

1 post

Affymax and Takeda Institute a Recall of OMONTYS

Posted by Buck Daniel February 25, 2013 – On February 23rd, Affymax and Takeda instituted a recall of OMONTYS following serious adverse reactions, including life threatening and fatal events. Omontys is used to treat anemia associated with chronic kidney disease for patients on dialysis. Anemia, in which the body is […]